¼±Åà - È»ìǥŰ/¿£ÅÍŰ
´Ý±â - ESC
KMLE °Ë»ö
°Ë»ö ¼³Á¤
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
»çÀÌÆ® ¼Ò°³
Àç°Ë»ö
"intermediate host"¿¡ ´ëÇÑ ´ëÇÑÀÇÇù ÀÇÇпë¾î ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
intermediate-acting insulin
Áß°£ÀÛ¿ëÀν¶¸°
reactive intermediate
¹ÝÀÀÁß°£¹°Áú
replicative intermediate
º¹Á¦Áß°£»ê¹°
accidental host
¿ì¿¬¼÷ÁÖ
definitive host
Á¾¼÷ÁÖ
final host
Á¾¼÷ÁÖ
graft versus host reaction
ÀÌ½ÄÆí´ë¼÷ÁÖ¹ÝÀÀ
graft-versus-host disease
ÀÌ½ÄÆí´ë¼÷ÁÖº´
host
¼÷ÁÖ
host adaptation
¼÷ÁÖÀûÀÀ
host attribute
¼÷ÁÖ¼Ó¼º
host defense
¼÷ÁÖ¹æ¾î
host integration factor
¼÷ÁÖÅëÇÕÀÎÀÚ
host preference
¼÷ÁÖ¼±È£
host range
¼÷ÁÖ¹üÀ§
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
intermediate density lipoprotein
Á߹еµÁöÁú´Ü¹é
intermediate cell mass
Áß°£¼¼Æ÷µ¢ÀÌ
intermediate field magnetic resonance scanner
ÁßµîÀÚÀåÀÚ±â°ø¸í½ºÄ³³Ê
reactive intermediate
¹ÝÀÀÁß°£¹°Áú
replicative intermediate
º¹Á¦Áß°£»ê¹°
posterior intermediate sulcus
µÚÁß°£°í¶û
abnormal host
ºñÁ¤»ó¼÷ÁÖ
accidental host
¿ì¿¬¼÷ÁÖ
alternate host
±³´ë¼÷ÁÖ
amplifier host
ÁõÆø¼÷ÁÖ
host adaptation
¼÷ÁÖÀûÀÀ
host attribute
¼÷ÁÖ¼Ó¼º
compromised host
ŸÇù¼÷ÁÖ
crustacean host
°©°¢·ù¼÷ÁÖ
definitive host
ÃÖÁ¾¼÷ÁÖ
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
6
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
graft-versus-host disease
ÀÌ½ÄÆí´ë ¼÷ÁÖº´
host
¼÷ÁÖ
host
¼÷ÁÖ
host adaptation
¼÷ÁÖÀûÀÀ.
pneumonia,in immunocompromised host
¸é¿ª±â´ÉÀúÇϼ÷ÁÖÀÇ (Øóæ¹Ñ¦Òöî¸ù»âÖñ«¡)
relation[ship], host-parasite
¼÷ÁÖ-±â»ýü »óÈ£°ü°è
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
host controlled variation
¼÷ÁÖÀÇÁ¸(±ÔÁ¦)º¯ÀÌ.
host defense
¼÷ÁÖ¹æ¾î
host factor
¼÷ÁÖÀÎÀÚ
host integration factor (HIF)
¼÷ÁÖÅëÇÕÀÎÀÚ
host range
¼÷ÁÖ¹üÀ§, ¼÷ÁÖ¿ª
host range mutation
¼÷ÁÖ¿ªº¯ÀÌ
host-controlled modification
¼÷ÁÖÁ¶Àý¼ö½Ä
host-parasite relationship
¼÷ÁÖ-±â»ýü »óÈ£°ü°è
host-parasite relationship
¼÷ÁÖ±â»ýü°ü°è
host-parasite relationships
¼÷ÁÖ ±â»ýÃæ(»ó°ü) °ü°è
host-range mutant
¼÷ÁÖ¹üÀ§º¯ÀÌÁÖ
mutant, host range
¼÷ÁÖ¿ª µ¹¿¬º¯ÀÌÁÖ
pneumonia,in immunocompromised host
¸é¿ª±â´ÉÀúÇϼ÷ÁÖÀÇ (Øóæ¹Ñ¦Òöî¸ù»âÖñ«¡)
relation[ship], host-parasite
¼÷ÁÖ-±â»ýü »óÈ£°ü°è
tumor host interaction
Á¾¾ç¼÷ÁÖ»óÈ£ÀÛ¿ë
ÀÌÀü
´ÙÀ½
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
ÅëÇÕ°Ë»ö ¿Ï·á
ÀÌÀü
´ÙÀ½